[1]朱晓珉,方文岩,陈军,等.CT导向下125I粒子植入治疗难治生肺癌的疗效观察[J].国际放射医学核医学杂志,2011,35(2):114-117.[doi:10.3760/cma.j.issn.1673-4114.2011.02.012]
　ZHU Xiao-min,FANG Wen-yan,CHEN Jun,et al.CT guided interstitial 125I seed implantation treatment of refractory lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(2):114-117.[doi:10.3760/cma.j.issn.1673-4114.2011.02.012]
点击复制

CT导向下125I粒子植入治疗难治生肺癌的疗效观察(/HTML)
分享到：

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
35
期数:
2011年第2期
页码:
114-117
栏目:
临床放射学
出版日期:
1900-01-01

文章信息/Info

Title:
CT guided interstitial 125I seed implantation treatment of refractory lung cancer
作者:
朱晓珉1;  方文岩2;  陈军2;  赵成2;  陈鹏3
1. 300193, 天津中医药大学第一附属医院CT室;
2. 300193, 天津中医药大学第一附属医院肿瘤科;
3. 300060, 天津市肿瘤医院肺内科
Author(s):
ZHU Xiao-min1;  FANG Wen-yan2;  CHEN Jun2;  ZHAO Cheng2;  CHEN Peng3
Department of CT, The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China
关键词:
肺肿瘤; 碘放射性同位素; 近距离放射疗法; 体层摄影术; X线计算机
Keywords:
Lung neoplasms; Iodine radioisotopes; Brachytherapy; Tomography; X-ray computed
DOI:
10.3760/cma.j.issn.1673-4114.2011.02.012
摘要:
目的 评价CT导向下125I粒子植入肿瘤组织间治疗难治性肺癌的临床价值。方法 共35例晚期难治性肺癌患者接受125I粒子植入治疗。术前采用治疗计划系统计算布源,术中将活度为2.855~3.087 MBq的125I粒子在CT导向下植入肿瘤组织间,粒子按照0.5~1.0 cm间距平面插植。肿瘤周边匹配剂量为150~180 Gy,每例患者植入粒子10~120颗。2个月后行CT复查评价疗效。结果 完全缓解4例、部分缓解27例、稳定3例、进展1例,客观应答率为88.57%。术中和术后发生严重气胸5例,均经胸腔闭式引流3~10 d后完全消失;轻度气胸7例未行任何处理而自愈,经随访发现,大多数患者毒性反应轻微并可耐受,未见大咳血、放射性肺炎等严重并发症。结论 CT导向下125I粒子植入治疗晚期难治性肺癌的疗效确切,创伤小,并发症发生率低。
Abstract:
Objective To evaluate the clinical value of CT guided interstitial 125I seed implantation treatment of refractory lung cancer. Methods A total of 35 cases of refractory lung cancer patients underwent 125I seed implantation treatment. Preoperative treatment planning system was used to calculate the distribution of radioactive source, then 2.855-3.087 MBq 125I seeds were implanted into the tumor tissues intraoperatively. Plane implantation of the particles were made every 0.5-1.0 cm. Matched peripheral dose was 150-180 Gy, and 10-120 particles were implanted for each patient, who would be followed up by CT to explore their efficacies two months later. Results Of the 35 patients, there were complete remission 4 cases,partial remission 27 cases, stable disease 3 cases, and progressive disease 1 cases. The objective response rate was 88.57%. Serious intraoperative and postoperative pneumothorax occurred in 5 patients, among whom transference cure was found 3-10 days later after their closed thoracic drainage, and 7 mild pneumothorax patients healed without more treatment. After follow-up it was found that most toxic reactions were mild and tolerable, and no severe complications were reported like hemoptysis or radiation pneumonia. Conclusion It is effective, less inasie and of low complication rate in CT guided interstitial 125I seed implantation treatment of advanced refractory lung cancer.

参考文献/References:

[1] 施长杲,吕维富.中晚期肺癌的介入治疗现状及进展.临床肺科杂志,2011,16(2):261-263.
[2] 焦德超,张福君,陆郦工,等.125I粒子组织间植入治疗肺恶性肿瘤.介入放射学杂志,2008,17(3):190-193.
[3] 易俊林,王绿化.评价实体瘤疗效的指导原则简介.国外医学临床放射学分册,2003,26(5):330-332.
[4] 中华医学会.临床诊疗指南肿瘤分册.北京:人民卫生出版社,2005:117-118.
[5] 张福君,吴沛宏,顾仰葵,都.CT导向下125I粒子植入治疗肺转移瘤.中华放射学杂志,2004,38(9):906-909.
[6] 胡效坤,张福君.CT介入治疗学.北京:人民卫生出版社,2009:156.
[7] 张文莉,高宏,杜伟生,等.诱导化疗配合局部植入放化疗粒子治疗晚期非小细胞肺癌的临床观察.临床肿瘤学杂志,2006,11(4):286-288.
[8] 张啸飞,高岩峰,刘兵,等.CT引导125I粒子植入治疗非小细胞肺癌75例分析.中国误诊学杂志,2010(3):652-653.
[9] 申文江,王绿化,夏延毅.放射治疗学新技术进展.北京:北京科学技术出版社,2003.155.
[10] 庞善军,燕军,解耀锃,等.CT导引下胸部病变穿刺活检不同方法的临床探讨.中国介入影像与治疗学,2007,4(5):348-350.

相似文献/References:

[1]梁雯丽,郑艳,李娜,等.Graves甲亢患者131I治疗后早期TRAb及TSAb变化的研究分析[J].国际放射医学核医学杂志,2016,40(1):13.[doi:10.3760/cma.j.issn.1673-4114.2016.01.003]
　Liang Wenli,Zheng Yan,Li Na,et al.Analysis of the changes in early TRAb and TSAb after 131I treatment for patients with Graves hyperthyroidism[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):13.[doi:10.3760/cma.j.issn.1673-4114.2016.01.003]
[2]麦卫平,张永林.能谱CT成像在肺癌诊断中的应用研究进展[J].国际放射医学核医学杂志,2016,40(1):77.[doi:10.3760/cma.j.issn.1673-4114.2016.01.015]
　Mai Weiping,Zhang Yonglin.Research progress of spectral imaging in the diagnosis of lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):77.[doi:10.3760/cma.j.issn.1673-4114.2016.01.015]
[3]邓艳,张伟.125I-碘酞酸盐临床应用进展[J].国际放射医学核医学杂志,2016,40(3):225.[doi:10.3760/cma.j.issn.1673-4114.2016.03.012]
　Deng Yan,Zhang Wei.125I-iothalamate clinical applications[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):225.[doi:10.3760/cma.j.issn.1673-4114.2016.03.012]
[4]田琦,蒋宁一,郑丽.265例精细个体化131I治疗Graves甲亢的疗效观察[J].国际放射医学核医学杂志,2016,40(4):259.[doi:10.3760/cma.j.issn.1673-4114.2016.04.004]
　Tian Qi,Jiang Ningyi,Zheng Li.Therapeutic effect of fine individual 131I treatment on Graves disease hyperthyroidism[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):259.[doi:10.3760/cma.j.issn.1673-4114.2016.04.004]
[5]杨珂,唐波,于夕荣,等.甲状腺癌131i治疗病房的辐射屏蔽计算与评价[J].国际放射医学核医学杂志,2015,39(5):405.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 012]
　yang ke,tang bo,yu xirong,et al.shielding calculation and assessment in 131i therapy for thyroid cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(2):405.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 012]
[6]霍小东,王慧星,阎卫亮,等.血管内皮抑制素对125I近距离照射裸鼠肺癌移植瘤的增敏效应研究[J].国际放射医学核医学杂志,2016,40(5):357.[doi:10.3760/cma.j.issn.1673-4114.2016.05.006]
　Huo Xiaodong,Wang Huixing,Yan Weiliang,et al.Sensitization effect of endostatin for 125I brachytherapy on transplanted tumor in nude mice[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):357.[doi:10.3760/cma.j.issn.1673-4114.2016.05.006]
[7]刘娇,程兵,常伟,等.非高危分化型甲状腺癌低剂量和高剂量131I清甲疗效的分析[J].国际放射医学核医学杂志,2016,40(6):419.[doi:10.3760/cma.j.issn.1673-4114.2016.06.004]
　Liu Jiao,Cheng Bing,Chang Wei,et al.Ablation efficacy in non-high-risk differentiated thyroid carcinoma patients with low-dose and high-dose 131I[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):419.[doi:10.3760/cma.j.issn.1673-4114.2016.06.004]
[8]徐蓉生,梅艳,赵力威,等.B超引导下术中125I粒子植入治疗晚期胰腺癌的疗效评价[J].国际放射医学核医学杂志,2016,40(6):424.[doi:10.3760/cma.j.issn.1673-4114.2016.06.005]
　Xu Rongsheng,Mei Yan,Zhao Liwei,et al.Evaluation of 125I particle implantation in the treatment of patients with advanced pancreatic neoplasms using B ultrasound-guided surgery[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):424.[doi:10.3760/cma.j.issn.1673-4114.2016.06.005]
[9]王越,晋建华,李思进,等.甲状腺24h摄碘率与131I治疗Graves甲亢疗效相关性研究[J].国际放射医学核医学杂志,2015,39(6):442.[doi:10.3760/cma.j.issn.1673-4114.2015.06.002]
　Wang Yue,Jin Jianhua,Li Sijin,et al.Correlation between thyroid 24 h of radioactive iodine uptake and clinical efficacy of 131I therapy for Graves’ hyperthyroidism[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(2):442.[doi:10.3760/cma.j.issn.1673-4114.2015.06.002]
[10]郭坤,高蕊,于燕,等.表皮生长因子受体基因表达与甲状腺功能亢进症131I治疗预后的关系[J].国际放射医学核医学杂志,2015,39(1):4.[doi:10.3760/cma.j.issn.1673-4114.2015.01.003]
　Guo Kun,Gao Rui,Yu Yan,et al.The relationship between epidermal growth factor receptor mRNA expression and the efficacv of 131I treatment in hyperthyroidism patients[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(2):4.[doi:10.3760/cma.j.issn.1673-4114.2015.01.003]
[11]张俊涛.晚期肺癌125I粒子植入治疗近期疗效观察[J].国际放射医学核医学杂志,2014,38(2):94.[doi:10.3760/cma.j.issn.1673-4114.2014.02.006]
　Zhang Juntao.Short-term efficacy of 125I seeds implantation in the treatment of advanced lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(2):94.[doi:10.3760/cma.j.issn.1673-4114.2014.02.006]
[12]廖江荣,蒲德利,程毅力,等.经纤支镜和经皮联合植入125I粒子治疗晚期肺癌气管狭窄的临床分析[J].国际放射医学核医学杂志,2013,37(3):165.[doi:10.3760/cma.j.issn.1673-4114.2013.03.009]
　LIAO Jiang-rong,PU De-li,CHENG Yi-li,et al.The clinical analysis of 125I particles implantation by fibrobronchoscope and percutaneous in the treatment of tracheal stenosis of advanced lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(2):165.[doi:10.3760/cma.j.issn.1673-4114.2013.03.009]
[13]胡丽丽,李小东,张雪宁,等.影像引导下125I粒子植入治疗肺癌的疗效分析[J].国际放射医学核医学杂志,2013,37(4):203.[doi:10.3760/cma.j.issn.1673-4114.2013.04.004]
　HU Li-li,LI Xiao-dong,ZHANG Xue-ning,et al.Efficacy of CT guided radioactive 125I seed implantation in the treatment of lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(2):203.[doi:10.3760/cma.j.issn.1673-4114.2013.04.004]
[14]姚红霞,张金山.微波消融和131I-肿瘤细胞核人鼠嵌合单克隆抗体联合治疗肺癌[J].国际放射医学核医学杂志,2012,36(5):264.[doi:10.3760/cnla.j.issn.1673-4114.2012.05.002]
　YAO Hong-xia,ZHA NG Jin-shan.Combination of microwave ablation and 131I labeled tumor necrosis therapy chimeric antibody in the treatment of lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(2):264.[doi:10.3760/cnla.j.issn.1673-4114.2012.05.002]
[15]张金山,邓咏梅.射频消融术和131I-肿瘤细胞核人鼠嵌合单抗治疗肺癌[J].国际放射医学核医学杂志,2009,33(3):159.[doi:10.3760/cma.j.issn.1673-4114.2009.03.008]
　ZHA NG din-shan,DENG Yong-mei.Radiofrequency ablation and Iodine-131 labeled nuclei of tumor cells chimeric monoclonal antibody radioimmunotherapy for the treatment of lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2009,33(2):159.[doi:10.3760/cma.j.issn.1673-4114.2009.03.008]
[16]刘建国,安丽青,程劲光,等.纤维支气管镜下植入125I粒子治疗中央型肺癌[J].国际放射医学核医学杂志,2009,33(5):291.[doi:10.3760/cnla.j.issn.1673-4114.2009.05.011]
　LIU Jian-guo,AN Li-qing,CHENG Jin-guang,et al.Efficacies of 125I seed implantation in advanced stage central lung cancer via fibrobronchoscope[J].International Journal of Radiation Medicine and Nuclear Medicine,2009,33(2):291.[doi:10.3760/cnla.j.issn.1673-4114.2009.05.011]

备注/Memo

备注/Memo:
收稿日期:2010-11-12。
通讯作者:陈鹏,Email:2qian@tongji.edu.cn
更新日期/Last Update: 1900-01-01